Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127611692 | 12761169 | 2 | F | 20160908 | 20160920 | 20160920 | EXP | IT-MINISAL02-373889 | IT-CIPLA LTD.-2016IT18181 | CIPLA | 0.00 | Y | 0.00000 | 20160920 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127611692 | 12761169 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | UNK | U | U | 0 | ||||||||
127611692 | 12761169 | 2 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
127611692 | 12761169 | 3 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | UNK | U | U | 0 | ||||||||
127611692 | 12761169 | 4 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127611692 | 12761169 | 1 | Myoclonic epilepsy |
127611692 | 12761169 | 2 | Myoclonic epilepsy |
127611692 | 12761169 | 3 | Myoclonic epilepsy |
127611692 | 12761169 | 4 | Myoclonic epilepsy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127611692 | 12761169 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127611692 | 12761169 | Epilepsy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |